Candidacy for non-surgical disc treatment—including intra-annular fibrin injection—is determined individually based on the nature of disc damage, duration of pain, prior treatment history, and overall health. Many patients with chronic discogenic pain who have not responded to conservative care may be good candidates; a thorough evaluation is the essential first step.

Understanding the Root Cause: Disc Damage and Chronic Pain

Chronic back pain often originates from damage to the intervertebral discs—the shock-absorbing cushions between vertebrae. Each disc has a tough outer layer called the annulus fibrosus and a gel-like interior called the nucleus pulposus. When either structure is compromised, persistent pain can follow.

Annular Tears

One of the most common—yet frequently overlooked—sources of chronic discogenic pain is an annular tear. These are fissures or rips in the disc’s outer wall. When tears develop, inflammatory proteins from the nucleus can leak outward, irritating nearby nerves and generating persistent pain. Tears also compromise the disc’s structural integrity, promoting further degeneration over time.

Degenerative Disc Disease (DDD)

Degenerative disc disease describes the progressive loss of disc hydration, height, and resilience that can occur with age, repetitive stress, or prior injury. As discs flatten and develop tears, the spine may become less stable, producing chronic pain and, in some cases, nerve compression.

Why Conventional Treatments May Fall Short

Many patients reach us after years of treatments that provided only temporary or incomplete relief. Understanding why these approaches have limitations can clarify the rationale for a biologic alternative:

• Physical Therapy: Valuable for building core stability and improving posture, but physical therapy alone does not repair a torn annulus or restore disc hydration.
• Medications: Pain relievers, muscle relaxants, and anti-inflammatory drugs address symptoms rather than underlying structural damage. Prolonged use may carry its own side-effect profile.
• Epidural Steroid Injections (ESIs): ESIs can temporarily reduce inflammation, but they do not promote disc healing. For many patients, pain returns once the steroid effect subsides.
• Spinal Fusion: For severe cases, fusion is sometimes recommended—but it eliminates motion at the treated segment, may accelerate degeneration at adjacent levels, and carries meaningful risks of incomplete relief. Patients exploring alternatives may find it worthwhile to seek a second opinion before committing to fusion.

Expert Take

When pain persists despite multiple rounds of conservative care, our clinical team looks for structural evidence on MRI that explains why the disc is not healing on its own. A confirmed annular tear or ongoing disc degeneration often signals that a more direct, regenerative approach may be warranted—though every case is evaluated individually before any recommendation is made.

Who May Be a Good Candidate for Non-Surgical Disc Treatment?

Our primary non-surgical approach is intra-annular fibrin injection—a biologic disc repair technique in which a fibrin solution is precisely delivered into damaged disc tissue, including annular tears. Fibrin is a natural clotting protein that acts as a scaffold, supporting the disc’s own repair processes and helping to seal fissures in the outer annulus. Candidates are evaluated individually; the following profile elements are commonly associated with favorable candidacy.

1. Chronic Back Pain Lasting Six Months or More

When back pain has persisted for at least six months and has not resolved with conservative management, it is unlikely to resolve spontaneously. This chronicity often points to an underlying structural issue—such as an unhealed annular tear—that may respond to biologic disc repair.

2. MRI Evidence of Disc Damage

Objective imaging findings are central to candidacy. Relevant MRI findings include:

• Annular tears: Often visible as high-intensity zones or disruptions in the annulus fibrosus. Sealing these tears is a primary goal of fibrin disc treatment.
• Degenerative disc disease: Patients with mild to moderate DDD—characterized by disc desiccation and reduced height—may benefit from biologic support to the remaining disc structure.
• Bulging or contained herniated discs: When a disc is bulging or mildly herniated without significant nerve compression or neurological deficit, biologic disc repair may help stabilize the segment and reduce the risk of further protrusion.

3. Inadequate Response to Conservative Treatments

A documented history of physical therapy, chiropractic care, pain medication, or epidural injections that did not deliver lasting relief is a meaningful indicator. It suggests a persistent structural problem that symptom-management approaches cannot fully address. Learn more about when non-surgical disc treatment may be a logical next step after conservative care has been exhausted.

4. Specific Conditions That May Respond to Biologic Disc Repair

• Chronic discogenic pain: Pain arising primarily from the intervertebral disc itself, often confirmed by provocation discography or characteristic MRI findings.
• Sciatica related to disc irritation: When sciatica is persistent and directly linked to a disc-level problem—without severe neurological deficits—biologic disc repair may help reduce the source of nerve irritation. Explore common myths about sciatica and non-surgical relief for additional context.
• Failed Back Surgery Syndrome (FBSS): Patients who continue to experience significant pain after prior spine surgery represent an important group. For those who are not good candidates for revision surgery, or who wish to avoid it, fibrin disc treatment may offer an alternative path. Outcomes in this group vary, and each case is assessed carefully.
• Contained disc herniation: When the outer annulus remains largely intact, fibrin can be delivered precisely to seal the tear and help prevent further nuclear material from extruding.

5. Realistic Expectations and Commitment to Recovery

Biologic disc repair supports the body’s own healing mechanisms—it is not an immediate fix. Patients who understand that meaningful improvement often unfolds over weeks to months, and who are prepared to follow post-treatment guidance (activity modification, graduated rehabilitation), tend to have more favorable experiences. Recovery timelines vary by individual.

6. General Medical Health

Candidates should be free of active infection, bleeding disorders, or other systemic conditions that would increase the risk of a minimally invasive procedure. A comprehensive health review is part of every evaluation.

Who May Not Be an Ideal Candidate?

Intra-annular fibrin injection is not appropriate for every clinical situation. Circumstances where it may not be the best first-line approach include:

• Acute injuries: Very recent disc injuries often benefit from a course of conservative management before more interventional approaches are considered.
• Progressive neurological deficits: Significant and worsening muscle weakness, foot drop, or bowel and bladder dysfunction may require prompt surgical decompression. These presentations are medical urgencies and should be evaluated immediately.
• Structural spinal instability: Conditions such as high-grade spondylolisthesis or significant scoliosis causing instability may require structural interventions that fibrin injection alone cannot provide.
• Active infection or spinal tumor: These must be identified and managed before any elective disc treatment is considered.
• Severe spinal stenosis: When significant central canal or foraminal stenosis is the primary pain driver, decompression may be necessary. Some disc-related contributions to stenosis may benefit from biologic care; each case is reviewed individually.
• Known contraindication to fibrin: Rarely, a patient may have an allergy or medical condition that makes fibrin-based treatment unsuitable.

The Evaluation Process at Valor Spine

Determining candidacy requires more than reviewing an MRI report. Our clinical team conducts a detailed evaluation that includes a thorough review of your medical history, prior treatment records, current imaging, and a structured physical examination. We look at the full picture—not just the images—to understand the relationship between your structural findings and your lived experience of pain.

If intra-annular fibrin injection is not the right fit, we will say so clearly and help you understand what options may be more appropriate. Our goal is to match each patient with a treatment path that is grounded in their specific anatomy, history, and goals—not a one-size-fits-all protocol.

For patients who have already undergone surgery and are still in pain, our article on whether biologic disc repair may be a next step after failed back surgery may be a helpful starting point.

Conditions Biologic Disc Repair May Help

To explore the range of disc and spine conditions that may respond to this approach, see our overview of conditions biologic disc repair may help. Veterans with service-connected disc conditions may also benefit from reviewing our guide on biologic disc repair for veterans.

Taking the Next Step

If you recognize yourself in the candidacy profile described above—or if you simply want a clearer picture of your options before committing to surgery—a consultation with our clinical team is the most direct path forward. We will review your history and imaging, answer your questions honestly, and help you understand whether biologic disc repair is a reasonable option for your situation.

Chronic disc pain does not have to define your daily life. Many patients who had spent years cycling through injections and physical therapy have found meaningful relief through intra-annular fibrin injection; outcomes vary, and there are no guarantees—but for appropriate candidates, the evidence supports this as a worthwhile option to evaluate.

For further reading, we recommend: 5 Non-Surgical Disc Treatments for Chronic Back Pain